Search Results 1781-1790 of 16569 for Maximum

1. Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery - Mayo Clinic

   For patients who receive adjuvant chemotherapy after surgery, a maximum of 12 weeks of intended chemotherapy may be administered but must be completed ...

2. Mayo Clinic Minute: Heart health and dangers of shoveling snow

   Shoveling snow can be good exercise and it can also be dangerous for people with heart conditions. Hear from a Mayo Clinic expert on why.

3. Publications - James P. Utz, M.D. - Mayo Clinic

   ... maximum exercise. Chest. 2009 May; 135 (5):1268-1279. View PubMed; Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, Thomeer M, Utz JP, Khandker ...

4. Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer - Mayo Clinic

   Receiving medications that can effect clotting ability: warfarin, aspirin (once-daily aspirin use- maximum dose 325 mg/day is permitted), nonsteroidal anti ...

5. Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma - Mayo Clinic

   ... maximum of 25 patients in this cohort. Note that the phase I is limited to the histologic subtypes listed above; since patients will be enrolling onto dose ...

6. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   NOTE: Prior treatment with corticosteroids (maximum dose of corticosteroids should not exceed the equivalent of 160 mg of dexamethasone over 14 days.

7. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

   ... maximum of 7 days is permitted prior to beginning the treatment, at the discretion of the investigator; a washout period does not apply; No known central ...

8. An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies - Mayo Clinic

   The purpose of this study is to evaluate the safety and tolerability, and determine the maximum tolerated dose of INCB062079 in subjects with advanced ...

9. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

   ... maximum of 100 weeks). Respiratory function is globally accepted for assessment of treatment effects in patients with lung fibrosis. The chosen endpoint ...

10. Select thyroid clinical trials at Mayo Clinic

    Mayo Clinic investigators are conducting a therapeutic pilot study for small papillary thyroid carcinomas that measure up to 1.5 cm in maximum diameter. The ...